EP Patent

EP1615626B1 — Tablet with coloured core

Assigned to Jagotec AG · Expires 2009-10-14 · 17y expired

What this patent protects

Press-coated tablets comprising a care and a coating. The core contains an active substance and a colouring agent such that when the tablet is exposed to penetrating radiation the core is contrasted with the coating and is visible through the coating. The invention also relates t…

USPTO Abstract

Press-coated tablets comprising a care and a coating. The core contains an active substance and a colouring agent such that when the tablet is exposed to penetrating radiation the core is contrasted with the coating and is visible through the coating. The invention also relates to the use' of a colouring agent or excipient in such tablets to determine whether the core is centrally located within the core, to check the integrity of the core, and to ensure that there is no contaminating core material on or near the surface the coating.

Drugs covered by this patent

Patent Metadata

Patent number
EP1615626B1
Jurisdiction
EP
Classification
—
Expires
2009-10-14
Drug substance claim
No
Drug product claim
No
Assignee
Jagotec AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.